The U.S. Food and Drug Administration on Thursday approved UroGen Pharma's drug to treat a type of bladder cancer, providing ...

Denmark's Novo Nordisk is partnering with biotech company Deep Apple Therapeutics in a deal worth up to $812 million to ...

For $812 million, Novo Nordisk will enlist Deep Apple to discover and develop a non-incretin therapy for obesity, months ...

The Federation of Kenya Pharmaceutical Manufacturers (FKPM) today met with Principal Secretary for Medical Services Dr. Ouma ...

Department of Pharmacology and Molecular Sciences, Johns Hopkins University, Baltimore, United States ...

They do that by negotiating prices with drug manufacturers, setting reimbursement rates paid to pharmacies, developing formularies, or “preferred drug lists,” and maintaining pharmacy networks ...

The U.S. healthcare system is the best in the world for complex care. We have the most innovative drug companies, the best medical devices, and incredible doctors and surgeons. The U.S. healthcare ...

The drug, called itepekimab, carries high hopes as the companies look for the next medicine that can produce the successes seen with Dupixent, their jointly marketed blockbuster. Dupixent is ...

Several store owners who testified on the bill during a March hearing said their dependence on pharmacy benefit managers, the middlemen between drug manufacturers and pharmacies, was the reason.

They do that by negotiating prices with drug manufacturers, setting reimbursement rates paid to pharmacies, developing formularies, or “preferred drug lists,” and maintaining pharmacy networks where ...

of 2022 may have increased drug manufacturer incentives to raise launch prices. “Instead, continued launch price growth for anticancer therapies was observed, consistent with prior research before the ...

For example, health officials, according to an executive order, will impose MFN only if drug manufacturers fail to make “significant progress” toward such pricing voluntarily. It’s unclear how such ...